Mode of hepatic spread from gallbladder carcinoma: An immunohistochemical analysis of 42 hepatectomized specimens

American Journal of Surgical Pathology

Volumn 34, Issue 1, 2010, Pages 65-74

  Wakai, Toshifumi ^a   Shirai, Yoshio ^a   Sakata, Jun ^a   Nagahashi, Masayuki ^a   Ajioka, Yoichi ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Gallbladder neoplasm; Immunohistochemistry; Liver metastasis; Lymphatic invasion; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOMA; GALLBLADDER TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 73949159344     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181c467d4     Document Type: Article

References (35)

1. Adson MA. Carcinoma of the gallbladder. Surg Clin North Am. 1973;53:1203-1216.
2. Alberts SR, Al-Khatib H, Mahoney MR, et al. Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial. Cancer. 2005;103:111-118.
3. Cho JY, Paik YH, Chang YS, et al. Capecitabine combined with gem-citabine (CapGem) as first-line treatment in patients with advanced/ metastatic biliary tract carcinoma. Cancer. 2005;104:2753-2758.
4. Cooper WA. Carcinoma of the gallbladder. Arch Surg. 1937;35: 431-448.
5. Dixon E, Vollmer CM Jr, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg. 2005;241:385-394.
6. Endo I, Shimada H, Takimoto A, et al. Microscopic liver metastasis: prognostic factor for patients with pT2 gallbladder carcinoma. World J Surg. 2004;28:692-696.
7. Fahim RB, McDonald JR, Richards JC, et al. Carcinoma of the gallbladder: a study of its modes of spread. Ann Surg. 1962;156:114-124.
8. Fleming ID, Cooper JS, Henson DE, et al. American Joint Committee on Cancer Staging Manual. 5th ed. Philadelphia: JB Lippincott; 1997:103-108.
9. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg. 2000;232:557-569.
10. Glenn F, Hays DM. The scope of radical surgery in the treatment of malignant tumors of the extrahepatic biliary tract. Surg Gynecol Obstet. 1954;99:529-541.
11. Greene FL, Page DL, Fleming ID, et al. American Joint Committee on Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002: 139-144.
12. Jones RS. Carcinoma of the gallbladder. Surg Clin North Am. 1990; 70:1419-1428.
13. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434-440.
14. Knox JJ, Hedley D, Oza A, et al. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol. 2005;23:2332-2338.
15. Koeberle D, Saletti P, Borner M, et al. Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcita-bine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. J Clin Oncol. 2008;26:3702-3708.
16. Kondo S, Nimura Y, Hayakawa N, et al. Extensive surgery for carcinoma of the gallbladder. Br J Surg. 2002;89:179-184.
17. Korita PV, Wakai T, Shirai Y, et al. Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepa-tectomy in patients with colorectal carcinoma liver metastases. Ann Surg Oncol. 2007;14:3472-3480.
18. Kornek GV, Schuell B, Laengle F, et al. Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. Ann Oncol. 2004;15:478-483.
19. Nakamura S, Sakaguchi S, Suzuki S, et al. Aggressive surgery for carcinoma of the gallbladder. Surgery. 1989;106:467-473.
20. Ohtsuka M, Miyazaki M, Itoh H, et al. Routes of hepatic metastasis of gallbladder carcinoma. Am J Clin Pathol. 1998;109:62-68.
21. Ouchi K, Owada Y, Matsuno S, et al. Prognostic factors in the surgical treatment of gallbladder carcinoma. Surgery. 1987;101:731-737.
22. Pack GT, Miller TR, Brasfield RD. Total right hepatic lobectomy for cancer of the gallbladder: report of three cases. Ann Surg. 1955; 142:6-16.
23. Pawlik TM, Gleisner AL, Vigano L, et al. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg. 2007;11:1478-1487.
24. Piehler JM, Crichlow RW. Primary carcinoma of the gallbladder. Surg Gynecol Obstet. 1978;147:929-942.
25. Reddy SK, Marroquin CE, Kuo PC, et al. Extended hepatic resection for gallbladder cancer. Am J Surg. 2007;194:355-361.
26. Shirai Y, Yoshida K, Tsukada K, et al. Radical surgery for gallbladder carcinoma: long-term results. Ann Surg. 1992;216:565-568.
27. Shirai Y, Yoshida K, Tsukada K, et al. Inapparent carcinoma of the gallbladder: an appraisal of a radical second operation after simple cholecystectomy. Ann Surg. 1992;215:326-331.
28. Shirai Y, Yoshida K, Tsukada K, et al. Identification of the regional lymphatic system of the gallbladder by vital staining. Br J Surg. 1992;79:659-662.
29. Shirai Y, Tsukada K, Ohtani T, et al. Hepatic metastases from carcinoma of the gallbladder. Cancer. 1995;75:2063-2068.
30. Shirai Y, Ohtani T, Tsukada K, et al. Combined pancreaticoduode-nectomy and hepatectomy for patients with locally advanced gallbladder carcinoma: long term results. Cancer. 1997;80:1904-1909.
31. Shirai Y, Wakai T, Hatakeyama K. Radical lymph node dissection for gallbladder cancer: indications and limitations. Surg Oncol Clin N Am. 2007;16:221-232.
32. Strasberg SM. The Brisbane 2000 Terminology of Liver Anatomy and Resections. HPB. 2000;2:333-339.
33. Takada T, Amano H, Yasuda H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95:1685-1695.
34. Wakai T, Shirai Y, Tsuchiya Y, et al. Combined major hepatectomy and pancreaticoduodenectomy for locally advanced biliary carcinoma: long-term results. World J Surg. 2008;32:1067-1074.
35. Yoshimitsu K, Honda H, Kuroiwa T, et al. Liver metastasis from gallbladder carcinoma: anatomic correlation with cholecystic venous drainage demonstrated by helical computed tomography during injection of contrast medium in the cholecystic artery. Cancer. 2001;92:340-348.